Unimark Remedies is an API manufacturer based in India. It holds 34 active US drug master files across a filed portfolio of 26 molecules. Its filings concentrate with EMA, INFARMED (PT) and FAMHP (BE). Its GMP standing is certified by CDSCO (India).
| Site | FDA FEI |
|---|---|
| Valsad, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Nitrofurantoin | US FDA | 4 |
| Cilastatin | US FDA | 2 |
| Doripenem | US FDA | 2 |
| Flecainide | US FDA | 2 |
| Imipenem | US FDA | 2 |
| Lisinopril | SFDA (Saudi Arabia), US FDA | 2 |
| Meropenem | US FDA | 2 |
| Moxifloxacin | SFDA (Saudi Arabia), US FDA | 2 |
| Ramipril | SFDA (Saudi Arabia), US FDA | 2 |
| Topiramate | US FDA | 2 |
| Albendazole | US FDA | 1 |
| Armodafinil | US FDA | 1 |
| Benazepril | US FDA | 1 |
| Buspirone | US FDA | 1 |
| Cefixime | US FDA | 1 |
| Cefuroxime | US FDA | 1 |
| Dronedarone | US FDA | 1 |
| Lamotrigine | US FDA | 1 |
| Meloxicam | US FDA | 1 |
| Monelukast | SFDA (Saudi Arabia) | 1 |
| Montelukast | US FDA | 1 |
| Paliperidone | US FDA | 1 |
| Pimozide | US FDA | 1 |
| Rizatriptan | US FDA | 1 |
| Solifenacin Succinate | US FDA | 1 |
| Tigecycline | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 4 | None |
| INFARMED (PT) | 3 | None |
| FAMHP (BE) | 3 | None |
| Health Canada | 2 | None |
| MINSA (CR) | 1 | None |
| CDSCO (India) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Unimark Remedies comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.